Avantax Planning Partners, Inc. Biogen Inc. Transaction History

Avantax Planning Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $81,322 - $103,003	-292 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $85,704 - $112,078	292 New	292 $103,000
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $27,297 - $32,532	-106 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $27,573 - $38,998	106 New	106 $28,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.